Ares Capital price target raised to $23.50 from $23.00 at BofA Securities

Published 05/08/2025, 17:30
Ares Capital price target raised to $23.50 from $23.00 at BofA Securities

Investing.com - BofA Securities has raised its price target on Ares Capital (NASDAQ:ARCC) to $23.50 from $23.00 while maintaining a Buy rating on the stock. Currently trading at $22.42, ARCC sits within the analyst target range of $22-$26, with a notable dividend yield of 8.57%.

The firm cited Ares Capital’s "steady quarter" which was driven by relatively healthy credit, decent portfolio growth, and solid liquidity. According to InvestingPro, ARCC maintains a "GOOD" Financial Health Score of 2.68, supporting BofA’s positive assessment. The business development company (BDC) has successfully raised both debt and equity capital during the period.

BofA Securities noted that yield pressure appears to be stabilizing for Ares Capital, and the company is seeing signs of improving transaction volume expected in the second half of 2025.

The investment bank believes these factors should support top and bottom-line growth for the BDC going forward.

BofA Securities considers Ares Capital "one of the best positioned BDCs to gain share and generate strong risk-adjusted returns" despite what it describes as a "more complex market backdrop."

In other recent news, Ares Capital reported stable earnings for the second quarter of 2025, with a GAAP net income per share of $0.52 and core earnings per share of $0.50, consistent with the previous quarter. The company also saw a 3% increase in its total portfolio at fair value, reaching $27.9 billion. Despite some market volatility, Ares Capital demonstrated resilience and strategic growth. Following these results, Citizens JMP raised its price target for Ares Capital to $23.00, maintaining a Market Outperform rating, citing solid earnings. Similarly, Keefe, Bruyette & Woods also increased their price target to $23.00, highlighting the company’s strong fundamentals despite missing street expectations. B.Riley upgraded Ares Capital’s stock rating from Neutral to Buy, raising the price target to $23.50, due to the company’s strong performance and portfolio quality. The firm noted that Ares Capital’s adjusted net investment income matched its expectations, while the company reported modest growth in net asset value. These developments reflect Ares Capital’s stable financial performance and positive outlook from analysts.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.